Although the evidence is mixed, some meta-analyses, which assess the combined data from many clinical trials, have linked celecoxib at higher or more frequent doses to an increased likelihood of ...

All 123 patients had a flare of OA at baseline, according to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and received celecoxib 200 mg once daily for 7 days.

All doses are once daily. Oropharyngeal candidiasis ... treat for at least 2 weeks after symptoms resolve; max 400mg/day. Systemic infections: doses of up to 400mg/day have been used.

All doses are once daily. Oropharyngeal candidiasis ... treat for at least 2 weeks after symptoms resolve; max 400mg/day. Systemic infections: doses of up to 400mg/day have been used.